BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6245569)

  • 21. Effects of prostaglandins on cyclic nucleotide phosphodiesterase activity in the human term placenta.
    Ferre F; Breuiller M; Cedard L
    Prostaglandins; 1982 May; 23(5):675-93. PubMed ID: 6289380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between prostaglandin E2 and prostacyclin in regulating levels of cyclic AMP in elicited populations of peritoneal macrophages.
    Bonta IL; Adolfs MJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():13-7. PubMed ID: 6303080
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandin actions and interactions on isolated perfused rat hearts.
    Karmazyn M; Leung CK; Dhalla NS
    Can J Physiol Pharmacol; 1979 Nov; 57(11):1275-82. PubMed ID: 391372
    [No Abstract]   [Full Text] [Related]  

  • 25. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
    Dusting GJ; Vane JR
    Circ Res; 1980 Jun; 46(6 Pt 2):I183-7. PubMed ID: 6991150
    [No Abstract]   [Full Text] [Related]  

  • 27. The dependence of cardiac eicosanoid effects on changes of calcium concentration.
    Mentz P; Pawelski KE
    Biomed Biochim Acta; 1984; 43(8-9):S167-70. PubMed ID: 6393963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of PGI2 and stable endoperoxide analogues on cyclic nucleotide levels in clonal cell lines of CNS origin.
    Ortmann R
    FEBS Lett; 1978 Jun; 90(2):348-52. PubMed ID: 208864
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of prostaglandins E1 and I2 on pulmonary thromboembolism- and hypoxia-induced responses in canine airways and the pulmonary vascular bed (author's transl)].
    Kitamura S; Ishihara Y; Sugiyama Y; Hsu LH
    Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Aug; 17(8):488-94. PubMed ID: 390192
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of PGI2 and CH-5084 on the arterial smooth muscle tone, blood pressure and platelet aggregation.
    Hadházy P; Malomvölgyi B; Hermán F; Magyar K; Kovács G
    Prog Clin Biol Res; 1987; 242():113-7. PubMed ID: 3313408
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostacyclin stimulation of dog arterial cyclic AMP levels.
    Miller OV; Aiken JW; Hemker DP; Shebuski RJ; Gorman RR
    Prostaglandins; 1979 Dec; 18(6):915-25. PubMed ID: 232764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PGE1 but not PGI2 desensitizes the PGI2 receptor-adenylate cyclase complex in human foreskin fibroblasts.
    Gorman RR; Hopkins NK
    Adv Prostaglandin Thromboxane Res; 1980; 8():1717-21. PubMed ID: 6246790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog.
    Au TL; Collins GA; Harvie CJ; Walker MJ
    Prostaglandins; 1979 Nov; 18(5):707-20. PubMed ID: 396577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells.
    Weissmann G; Smolen JE; Korchak H
    Adv Prostaglandin Thromboxane Res; 1980; 8():1637-53. PubMed ID: 6246786
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base.
    Kukovetz WR; Holzmann S
    Z Kardiol; 1985; 74 Suppl 1():39-44. PubMed ID: 2986371
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.